Improving access to effective antibiotics: Novel Medicines Platform working group aiming for consensus

  14 June 2024

WHO’s Novel Medicines Platform (NMP) has launched a working group on novel antimicrobials in Stockholm, Sweden, to explore policy alternatives to promote sustainable innovation of novel antibiotics and ensure access to older, existing ones. The group aims to develop proposals on concrete multistakeholder actions to enhance existing initiatives to promote access to antibiotics. The current antimicrobial research and development pipeline is inadequate in addressing the escalating emergence and spread of antimicrobial resistance (AMR), with financial risk and lower expected return on investment being significant deterrents. The NMP will bring together stakeholders from the WHO European Region to build consensus on this issue, allowing for consultation and prioritization of proposals. Prioritized proposals and deliverables will act as proofs of concept for future scale-up and implementation across the Region.

Further reading: WHO
Author(s): WHO
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed